Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial

Archives of General Psychiatry

Volumn 54, Issue 8, 1997, Pages 700-705

  Cornelius, Jack R ^a   Salloum, Ihsan M ^a   Ehler, Joan G ^a   Jarrett, Patricia J ^a   Cornelius, Marie D ^a   Perel, James M ^a   Thase, Michael E ^a   Black, Ann ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0030860546     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830200024004     Document Type: Article

References (33)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Åsberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. Arch Gen Psychiatry. 1976;33:1193-1197.
3. Takahashi S, Yamane H, Kondo H, Tani N, Kato N. CSF monoamine metabolites in alcoholism: a comparative study with depression. Folia Psychiatr Neurol. 1974;28: 347-354.
4. Traskman L, Åsberg M, Bertilsson L, Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry. 1981;38:631-636.
5. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986;43:954-959.
6. Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry. 1979;36:224-227.
7. Banki CM, Arato M, Papp Z, Kurcz M. Biochemical markers in suicidal patients. J Affect Disord. 1984;6:341-350.
8. Banki CM. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect. 1981;50:89-101.
9. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci. 1986;9:319-364.
10. Roy A, DeJong J, Lamparski D, Adinoff B, George T, Moore M, Garnett D, Kerich M, Linnoila M. Mental disorders among alcoholics. Arch Gen Psychiatry. 1991; 48:423-427.
11. Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG, Mann JJ. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull. 1993; 29:195-199.
12. Lawrin MO, Naranjo CA, Sellers EM. Identification and testing of new drugs for modulating alcohol consumption. Psychopharmacol Bull. 1986;22:1020-1025.
13. Naranjo CA, Sellers EM, Lawrin MO. Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry. 1986;47:16-22.
14. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther. 1990;47:490-498.
15. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL. Fluoxetine attenuates alcohol intake and desire to drink. Int Clin Psychopharmacol. 1994;9:163-172.
16. Naranjo CA, Sullivan JT, Kadlec KE, Woodley-Remus DV, Kennedy G, Sellers EM. Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther. 1989;46:301-309.
17. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther. 1987;41:266-274.
18. Gorelick DA, Paredes A. Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res. 1992;16:261-265.
19. Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacol Bull. 1995;31:297-303.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
21. Spitzer RL, Williams JBW, Gibbon M, First MB. Instructional Manual for the Structured Clinical Interview for DSM-III-R (SCID), Revised. New York: Biomedical Research Division, New York State Psychiatric Institute; 1988.
22. Cornelius JR, Jarrett PJ, Thase ME, Fabrega H, Haas GL, Jones-Barlock A, Mezzich JE, Ulrich RF. Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry. 1995;36:435-440.
23. Cornelius JR, Fabrega H, Cornelius MD, Mezzich JE, Maher PJ, Salloum IM, Thase ME, Ulrich RF. Racial effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry. 1996;37:102-108.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
26. Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict. 1988;83:393-402.
27. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J Nerv Ment Dis. 1980;168:26-33.
28. Norusis MJ. SPSS for Windows: Base System User's Guide, Release 5.0. Chicago, III: SPSS; 1992.
29. Cornelius JR, Salloum IM, Mezzich J, Cornelius MD, Fabrega H, Ehler JG, Ulrich RF, Thase ME, Mann JJ. Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry. 1995;152:358-364.
30. Cornelius JR, Salloum IM, Day NL, Thase ME, Mann JJ. Patterns of suicidality and alcohol use in alcoholics with major depression. Alcohol Clin Exp Res. 1996; 20:1451-1455.
31. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, Quitkin FM. Imipramine treatment of alcoholics with major depression: a placebo-controlled clinical trial. Arch Gen Psychiatry. 1996;53:232-240.
32. Mason BJ, Kocsis JH, Ritvo CE, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 1996;275:761-767.
33. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry. 1995;152:391-397.